Pipe SW, Hermans C, Chitlur M, Carcao M, Castaman G, Davis JA, et al. Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors. Haemophilia. 2022;28(4):548-56. https://pubmed.ncbi.nlm.nih.gov/35475308/
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors.
By Peter Matlawa|2023-04-13T10:27:23+02:00April 13, 2023|2022: April to June|Comments Off on Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors.
Share This Story, Choose Your Platform!
About the Author: Peter Matlawa
Related Posts
Antimicrobial susceptibility and genomic profiling of Salmonella enterica from bloodstream infections at a tertiary referral hospital in Lusaka, Zambia, 2018-2019.